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Human immunodeficiency virus type 1 (HIV-1) infects
the central nervous system and plays a direct role in the
pathogenesis of AIDS dementia. However, the molecular
mechanisms underlying HIV-1 expression in the central
nervous system are poorly understood. We have recently
reported that the nuclear receptor chicken ovalbumin
upstream promoter transcription factor (COUP-TF), an
orphan member of the nuclear receptor superfamily, is
an activator of HIV-1 gene transcription. Here, our re-
sults show that COUP-TF stimulates HIV-1 transcription
in primary cultured human microglial cells, the primary
target for HIV-1 infection in brain. Run-on assays indi-
cated that COUP-TF acts on the initiation step of tran-
scription. Results from reverse transcription-polymer-
ase chain reaction and immunocytochemistry analysis
further revealed the importance of this factor by dem-
onstrating that overexpression of COUP-TF leads to ini-
tiation of viral replication in primary HIV-infected hu-
man microglia. In addition, COUP-TF is able to
physically interact and cooperate with the viral trans-
activator Tat. The combination of COUP-TF and Tat
leads to NF-kB- and Sp1-independent enhanced tran-
scriptional stimulation. In vitro binding studies showed
that COUP-TF interacts with Tat through amino acids
within the N-terminal DNA-binding domain of COUP-
TF. Amino acids 48–72 in the basic and C-terminal re-
gions of Tat are required for the binding of Tat to COUP-
TF. These results suggest that COUP-TF is an essential
transcription factor involved in HIV-1 expression in mi-
croglia and reveal a novel interplay of Tat and COUP-TF
during regulation of viral expression.
Human immunodeficiency virus type 1 (HIV-1)1 infects the
central nervous system (CNS) and leads to a wide range of
neurological complications (1, 2). Although astrocytes, oligo-
dendrocytes, and perhaps neurons are capable of harboring a
restricted infection with HIV-1 (3–5), the CNS-resident macro-
phages or microglial cells (6) are the primary target of HIV-1
infection in brain (7–10). HIV-1 infection is established in the
CNS by viruses present early in infection (11). Macrophage-
tropic isolates infect microglial cells more efficiently than do
lymphotropic isolates (12). We have therefore performed our
studies with both a macrophage-tropic and a lymphotropic
strain.
The regulation of HIV-1 gene expression is governed by
interactions of viral and host cell transcription factors with the
long terminal repeat (LTR) region (for review, see Refs. 13 and
14). Recent studies have focused on cellular factors that regu-
late HIV-1 expression in CNS cells (15–18). Our previous stud-
ies have highlighted the importance of members of the steroid/
thyroid/retinoid receptor family in the regulation of HIV-1 gene
transcription in brain cells. We have shown that the orphan
nuclear receptor COUP-TF/Ear3 (19) function as a potent
HIV-1 transcriptional activator in different human brain cell
lines. Whereas in oligodendrocytes, COUP-TF acts by direct
interaction with the nuclear receptor-responsive element lo-
cated in the 2352/2320 LTR region (17), in microglial cells,
COUP-TF enhances transcription via the minimal 268/129
LTR region by direct association with the Sp1 protein (18).
These transcription factors activate LTR-driven transcrip-
tion in the immediate-early phase of HIV infection, in which
viral transcription proceeds at a low rate through dependence
solely on cellular transcription factors. This leads to the early
phase, in which a dramatic increase in transcription results
from the accumulation of the primary transactive viral protein
Tat (14, 20). A number of studies have shown that Tat in-
creases the rate of transcription initiation, elongation and
translation of TAR-containing mRNAs. The ability of Tat to
function as a transcriptional activator is mediated by the in-
teraction with a number of different cellular proteins (for re-
view, see Ref. 20). The general transcription factors TBP/TFIID
(21) and TFIIH (22) and the elongation factors TAK/PTEFb (23,
24) and cyclin T (25) associate with Tat. In addition, transcrip-
tional activation by Tat requires the concerted action of Tat and
factors binding to the Sp1 and kB LTR region. The importance
of the Sp1 factor for Tat-mediated transactivation is well es-
tablished (26, 27); a direct interaction occurs between Sp1 and
amino acids 30–72 of Tat during transactivation (26, 28, 29).
Specific NF-kB subunits also act in concert with Tat to enhance
LTR-driven transcription (30, 31). Moreover, the thyroid hor-
mone receptor T3Ra, a member of the nuclear receptor super-
family, was found to interact with Tat through amino acids
located in the DNA-binding domain of T3Ra and through
amino acids 49–72 in the basic and C-terminal region of Tat
* This work was supported by INSERM (U338 and CRI 96–12), the
Agence Nationale des Recherches sur le SIDA, the Fondation pour la
Recherche Medicale, Universite´ Paris-Sud, and the association “Le
Cercle d’Emeraude.” The costs of publication of this article were de-
frayed in part by the payment of page charges. This article must
therefore be hereby marked “advertisement” in accordance with 18
U.S.C. Section 1734 solely to indicate this fact.
§ Recipient of financial support from the association “Ensemble con-
tre le SIDA” and Fondation pour la Recherche Medicale (Sidaction).
i To whom correspondence should be addressed: Gladstone Institute
of Virology and Immunology, P. O. Box 419100, San Francisco, CA
94141-9100. Tel.: 415-695-3806; Fax: 415-826-1514; E-mail:
eschaeffer@gladstone.ucsf.edu.
1 The abbreviations used are: HIV-1, human immunodeficiency virus
type 1; CNS, central nervous system; LTR, long terminal repeat; COUP-
TF, chicken ovalbumin upstream promoter transcription factor; CAT,
chloramphenicol acetyltransferase; PIPES, 1,4-piperazinediethanesul-
fonic acid.
THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 275, No. 4, Issue of January 28, pp. 2654–2660, 2000
© 2000 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A.
This paper is available on line at http://www.jbc.org2654
 by guest on M
arch 4, 2015
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
(32). These data explain why mutations within the LTR se-
quence decrease or abolish Tat-mediated activation (33, 34).
Interestingly, TAR-independent Tat transactivation has also
been described, in the presence of an intact NF-kB element (35,
36).
In this report, we have investigated the functional effect of
the nuclear receptor COUP-TF on HIV-1 gene expression in
primary cultured human microglial cells. Our results reveal
the importance of COUP-TF as an activator of HIV-1 gene
transcription and replication in primary microglia. In addition,
we provide evidence for a novel functional and physical inter-
action between COUP-TF and Tat. This interaction leads to
enhanced synergistic NF-kB and Sp1-independent transactiva-
tion of the LTR. Our data suggest a model of an alternative
pathway for Tat transactivation in microglia that is independ-
ent of both NF-kB and Sp1, through direct interactions of Tat
with the nuclear receptor COUP-TF.
MATERIALS AND METHODS
Plasmids—LTR-chloramphenicol acetyltransferase (CAT) vectors
were described previously (16–18). LTR-CAT Sp1mut and LTR-CAT
DkB/Sp1 and pCMVp53 were a gift from Dr. B. E. Sawaya (Philadel-
phia, PA). The GST-COUP-1 and GST-COUP-3 vectors were described
(18). To construct T7-Tat, the Tat fragment was excised from pCMV-Tat
vector (gift of Dr. N. Israel, Institut Pasteur, Paris France) and sub-
cloned into the pCDNA3 vector (Invitrogen). To construct T7-COUP-TF,
the plasmid RSV-COUP-TF (gift of Dr. M. J. Tsai, Houston, TX) was
digested with EcoRI and the COUP-TF insert was subcloned into the
EcoRI site of pCDNA3. To construct pCMV-Tat 72R P18IS, the Tat 72R
P18IS sequence (from Dr. A. Rice, AIDS Research and Reference Rea-
gent Program, Division of AIDS, NIAID, National Institutes of Health)
was excised from GST-Tat 72R P18IS vector and subcloned into the
pCDNA3 vector. To construct the 240/180-SV40 TATA-CAT vector, the
240/180 HIV-1 LTR containing the HIV-1 LAI TATA box (TATAAGC)
was mutated by PCR into the SV40 virus TATA box (TATTTAT) and
subcloned into the pMOSBlue T-vector (Amersham Pharmacia Bio-
tech). The 1.6-kilobase region containing the CAT reporter gene and
polyadenylation signals was subcloned in the HindIII site in front of the
modified 240/180 LTR.
Cell Culture, Transfections, and CAT Assays—Two types of micro-
glial cell cultures were tested: primary cells and a cell line. Primary
human fetal microglial cells were prepared as described previously (37).
They were plated in 6-cm-diameter dishes and were transfected either
by the calcium phosphate precipitation method or with the Escort
reagent (Sigma) following the manufacturer’s instructions. The human
microglial cell line (38) was grown in Dulbecco’s modified Eagle’s me-
dium supplemented with 10% fetal calf serum and 10 mM HEPES in the
presence of penicillin-streptomycin (100 units/ml) and was transfected
by the calcium phosphate coprecipitation method.
Cells were either transfected with 1 pmol of plasmid reporter DNA or
cotransfected with 1 pmol of reporter DNA and 0.5 pmol of the indicated
expression vector: RSV-COUP-TF (gift of Dr. M. J. Tsai, Houston, TX),
CMV-p53 (gift of Dr. B. E. Sawaya, Philadelphia, PA), pEF-NF-IL6 (gift
of Dr. S. Akira, Hyogo, Japan), or CMV-Sp1 (gift of Dr. R. Tjian,
Berkeley, CA). Each transfection was done in duplicate and repeated a
minimum of three separate times with two different plasmid prepara-
tions. CAT assays were done using standard techniques (16).
Infection of Cells and RT-PCR Analysis—Primary cells (3–4 3 105)
were incubated with HIV-1 LAI or 95.33 (titer of 15–20 ng/ml of p24) for
18 h at 37 °C and then washed four times to remove residual virus.
When indicated, cells were transfected 18 h postinfection. At 24 and
48 h posttransfection, total RNA was prepared with the RNable kit
(Eurobio), and gp120 mRNA detection was performed by RT-PCR anal-
ysis, using gp120 59 biotinylated primer, TAGGACGAGCAATGTAT-
GCC, (0.25 pmol) and 39 primer, TATATAATTCACTTCTCCAATTGTC-
CCTCAT (0.25 pmol). PCR was performed in a 50-ml PCR mixture
containing 10 nmol of each dNTP, 0.25 pmol of each primer, and 1.25
units of Taq DNA polymerase (AmpliTaq gold, Perkin Elmer). PCR
products were visualized after ethidium bromide staining and agarose
gel electrophoresis.
Immunocytochemistry—Primary cells incubated with HIV-1 (LAI)
and transfected as described above were tested by immunochemistry
after 24 h posttransfection and fixation in acetone for 8 min. Primary
antibodies were mouse IgG1 directed against HIV-1 p24 and HIV-1 Tat
(1:200, AIDS Research and Reference Reagent Program, Rockville,
MD). The immunostaining was revealed by secondary peroxidase-con-
jugated antibodies and visualized with diaminobenzidine (0.6 mg/ml,
DAKO) and 0.01% hydrogen peroxide.
GST Pull-down Assays—GST and GST fusion proteins were ex-
pressed in Escherichia coli BL-21(DE3). GST-Tat expression vectors
were obtained through the AIDS Research and Reference Reagent
Program, Division of AIDS (NIAID, National Institutes of Health) from
Dr. A. Rice (23, 39). Overnight cultures of bacteria that were newly
transformed with the plasmids were diluted with 20 volumes of me-
dium, cultured for several hours to an absorbance at 600 nm of 0.6 and
induced with 0.4 mM isopropyl b-D-thiogalactopyranoside at 37 °C for
3 h. Bacteria from 125 ml of culture were harvested and resuspended in
1.5 ml of NETN (20 mM Tris, pH 8, 100 mM NaCl, 1 mM EDTA, 0.5%
Nonidet P-40, 10 mg of leupeptin per ml, 10 mg of pepstatin per ml, 10
mg of aprotinin per ml, 1 mM phenylmethylsulfonyl fluoride). The ly-
sates were sonicated and after centrifugation, the supernatants were
mixed with glutathione-Sepharose 8A beads (40 ml, Pharmacia) at 4 °C
overnight in NETN buffer. The 35S-labeled input Tat or COUP-TF
protein was prepared by in vitro translation using the TNT T7 system
(Promega) according to the manufacturer’s suggestions. The coated
beads (40 ml) were washed with NETN and further incubated for 2 h at
4 °C with 15 ml of the total in vitro translated protein reaction mixture
in a final volume of 300 ml of binding buffer (50 mM Tris-HCl, pH 7.6, 50
mM NaCl, 0.02% Tween 20, 0.02% bovine serum albumin) containing
antiproteases as in NETN. After extensive washing with washing
buffer (50 mM Tris-HCl, pH 7.6, 150 mM NaCl, 0.02% Tween 20) con-
taining the antiproteases, the bound proteins were dissociated by boil-
ing for 3 min in Laemmli sample buffer and subjected to SDS-polyacryl-
amide gel electrophoresis.
Immunoprecipitations and Western Blot Analysis—Lysates were pre-
pared from cells plated in a 10-cm dish, as described (18). Cell lysates
were resuspended in 400 ml of TNE (50 mM Tris, pH 8.0, 1% Nonidet, 2
mM EDTA, and a mixture of protease inhibitors), mixed with protein
A-agarose beads (20 ml), and gently shaken for 1 h at 4 °C. The suspen-
sion was briefly centrifuged, and the supernatant was mixed with 3 ml
of monoclonal antibodies against HIV-1 (BH10) Tat (obtained through
the AIDS Research and Reference Reagent Program, Division of AIDS,
NIAID, National Institutes of Health, from Drs. K. Krohn and V. Ovod
(40). After overnight incubation at 4 °C, protein A-agarose (30 ml) was
added and mixed for 2 h. After extensive washing of the beads with
TNE, 15 ml of beads were mixed with 5 ml of Buffer Z (20 mM HEPES,
pH 7.9, 1 mM MgCl2, 60 mM KCl, 0.5 mM EDTA, 1 mM dithiothreitol,
10% glycerol) and processed for Western blotting, with COUP-TF anti-
bodies (a gift from Dr. K. Karathanasis; Philadelphia, PA).
Run-on Analysis—Microglial cells were harvested, suspended in lysis
Buffer A (0.3 M sucrose, 60 mM KCl, 15 mM NaCl, 15 mM Tris, pH 7.5,
0.5 mM spermidine, 0.15 mM spermine, 2 mM EDTA, 0.5 mM EGTA, 14
mM b-mercaptoethanol), and spun down at 1500 3 g for 5 min. The
pellet was resuspended in 3 ml of Buffer B (Buffer A plus 0.1% Triton
X), poured gently on 4 ml of Buffer C (Buffer A with 0.7 M sucrose), and
spun down at 2500 3 g for 10 min. The permeabilized nuclei were
resuspended in storage Buffer D (50 mM HEPES, pH 8, 1 mM MgCl2, 0.5
mM dithiothreitol, 1 mg/ml bovine serum albumin, and 25% glycerol)
and stored at 280 °C.
1 mg of CAT (LTR-CAT HindIII-excised total CAT gene), 1 mg of CAT
I (240/179 LTR-CAT AlwNI/HindIII fragment), and 1 mg of CAT II
(179/1229 HindIII/PvuII CAT fragment) were excised from the LTR-
CAT vector, single-stranded and applied onto a nitrocellulose filter
preincubated in 2 M ammonium acetate. After 2 h in a vacuum oven at
80 °C, filters were washed with 13 SSC, 0.1% SDS and prehybridized
for 1 h in reaction buffer (50 mM HEPES, pH 8, 1 mM MgCl2, 2 mM
MnCl2, 4 mM dithiothreitol, 200 mM KCl, 300 mM NH4Cl) containing 20
mg/ml tRNA. Filters were boiled for 1 min and cooled in ice-cold water
before use or were stored in a plastic bag at 4 °C.
The elongation reaction was carried out with 50 ml of isolated and
permeabilized nuclei for 20 min at 26 °C in reaction buffer supple-
mented with 1 mg of LTR-CAT vector, 200 mCi of [32P]UTP, 0.5 mM of
other NTP, and 30 units of RNasin inhibitor (New England Biolabs).
The mRNA transcripts were phenol extracted and precipitated succes-
sively with 10% (w/w) trichloroacetic acid and ethanol. The pellet was
dissolved in 10 mM Tris, pH 7.5, supplemented with 1% SDS, applied to
the previously prepared nitrocellulose filters in hybridization buffer
(0.5 mM NaCl, 50 mM PIPES, pH 7, 33% formamide, 0.4% SDS, 2 mM
EDTA, and 20 mg/ml tRNA), and incubated at 45 °C for 72 h. Filters
were washed twice with 23 SSC, 0.1% SDS at room temperature for 30
min and twice with 0.1% SSC, 0.1% SDS at 55 °C for 15 min. Filters
were exposed overnight on a BIOMAX MR film (Eastman Kodak Co.).
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RESULTS
COUP-TF Stimulates HIV-1 Transcription in Primary Hu-
man Microglial Cells—We have previously shown that the
transcription factor COUP-TF stimulates HIV-1 LTR-driven
transcription in a microglial cell line (18). Because we also
detected endogenous COUP-TF in primary cultures of micro-
glial cells (results not shown), it appeared essential to examine
how COUP-TF regulates HIV-1 gene transcription and viral
replication in these cells. Transfection experiments were per-
formed with a LTR-CAT reporter vector in primary cultures of
microglial cells containing the CAT gene under the control of
the HIV-1 LTR region. When cells were cultured in the absence
of cytokine stimulation and transfected with the calcium copre-
cipitation method, the basal transcriptional activity was barely
detectable (Fig. 1A). This is consistent with our recent results,
which showed that HIV-1 expression in cultured microglial
cells is dependent on prestimulation with proinflammatory
cytokines (37). Upon cotransfection with the COUP-TF expres-
sion vector, LTR-driven CAT expression was induced 20-fold.
As a control, overexpression of the tumor suppressor p53,
which is known to repress HIV-1 transcription (41), did not
induce any CAT activity (Fig. 1A). When cells were transfected
with a cationic liposome (Fig. 1B), the transfection efficiency
was better. The basal transcription activity remained quite
low. Interestingly, the level of induction following COUP-TF
overexpression was 19-fold, similar to the one obtained in Fig.
1A. Moreover, upon overexpression of the positive transactiva-
tors Sp1 and NF-IL6, CAT activity was induced 25- and 27-fold.
These results confirm that, similar to the situation observed in
brain cell lines, COUP-TF, Sp1, and NF-IL6 function as HIV-1
transcriptional activators in primary microglia.
COUP-TF Stimulates the Initiation Step of HIV-1 Gene Tran-
scription—To investigate at which step COUP-TF enhances
HIV-1 gene expression, we performed run-on assays using iso-
lated nuclei from microglial cells that had been transfected
with COUP-TF or left untransfected (Fig. 2). In the absence of
COUP-TF overexpression, transcription in the CAT reporter
gene was low; overexpression of COUP-TF led to a large in-
crease in the transcription rate (Fig. 2A), confirming its tran-
scriptional stimulatory activity. To test whether COUP-TF
acted on the initiation or the elongation step of transcription,
run-on assays were performed with CAT I (240/179 LTR-CAT
AlwNI/HindIII fragment) and CAT II (179/1229 HindIII/
PvuII CAT fragment). COUP-TF increased the amount of small
mRNAs because the amount of transcripts of CAT I was higher
than that of CAT II (Fig. 2B). This result indicates that
COUP-TF acts on the initiation step of transcription.
COUP-TF Stimulates Replication in Primary Human Micro-
glial Cells—To investigate the effect of COUP-TF on viral
replication itself, we devised a novel experimental procedure.
Primary cultures of microglial cells were first infected with
either the lymphotropic LAI or the macrophage-tropic 95.33
HIV-1 strain (37). After 18 h, cells were either treated with the
transfection reagent alone or transfected with the COUP-TF
vector. Expression of the viral gp120 mRNA after 24 and 48 h
was monitored by RT-PCR analysis. Results clearly showed
that overexpression of COUP-TF induces gp120 expression,
peaking at 24 h, similar to the expression obtained in T lym-
phocytes (Fig. 3). As a control, transfection with a vector ex-
pressing the tumor suppressor p53, known to repress LTR-
driven transcription (42) did not induce any gp120 expression
(results not shown).
In addition, we performed immunocytochemistry experi-
ments with primary cultured microglial cells infected with
HIV-1 and transfected with the COUP-TF vector or left un-
transfected. The percentage of transfected cells with the Escort
FIG. 3. COUP-TF stimulates HIV-1 mRNA production in pri-
mary cultured human microglial cells. Cells (4 3 105) were infected
with HIV-1(LAI) and after 18 h were transfected with the COUP-TF
vector or left untransfected. Expression of HIV-1 gp120 mRNA was
measured 24 and 48 h posttransfection by RT-PCR analysis. PCR
products were visualized by gel electrophoresis. HIV-1 gp120 mRNA
was detected as a 160-base pair fragment (160 base pairs). mRNA from
infected T cells was used as a control.
FIG. 1. COUP-TF stimulates HIV-1 LTR-driven transcription
in primary cultured human microglial cells. Transfection experi-
ments were performed in primary microglia with the HIV-1 LTR-CAT
vector in the absence or presence of a vector expressing COUP-TF, p53,
NF-IL6, or Sp1, as indicated. One typical CAT assay is shown after
transfection by the calcium phosphate coprecipitation method (A) and
with the Escort reagent (Sigma) (B). At the top of the autoradiograms
are indicated the percentage of conversion into the acetylated forms of
chloramphenicol and the CAT activities expressed relative to the value
obtained with the LTR-CAT reporter vector alone.
FIG. 2. Nuclear run-on analysis. Microglial cells were transfected
with COUP-TF expression vector (1) or left untransfected (2). Nuclei
were permeabilized and subjected to a 15-min in vitro transcription
assay. A, two aliquots of 1 mg of the CAT gene (excised from LTR-CAT
vector) were spotted onto nitrocellulose papers and used in hybridiza-
tion assays as described under “Materials and Methods.” B, aliquots of
1 mg of CAT I (240/179 LTR-CAT AlwNI/HindIII DNA fragment) and
CAT II (179/1229 HindIII/PvuII LTR-CAT DNA fragment) were spot-
ted onto nitrocellulose paper as indicated under “Materials and Meth-
ods” and used in hybridization assays.
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reagent, determined by transfection of the green fluorescent
protein, was between 5 and 10% (results not shown). Results
showed that cells transfected with COUP-TF expressed HIV-1
antigen proteins p24 (Fig. 4, B and C) and Tat (Fig. 4D). As a
control, cells that were infected, but not transfected with
COUP-TF, did not express any HIV-1 antigen (Fig. 4A). In Fig.
4, B–D, we have selected an area of transfected cells, because
cells expressing viral antigens were found mostly in clusters,
scattered on the preparation. Taken together, these findings
demonstrate that, consistent with the effect on transcription,
overexpression of COUP-TF is able to initiate viral replication.
Interestingly, this effect was observed with both a lympho-
tropic strain of HIV-1 that otherwise replicates very poorly in
microglia and a macrophage-tropic strain.
Effect of COUP-TF on HIV-1 Expression in the Presence of
Viral Tat—It is well established that in the early phase of HIV
infection, a dramatic increase in transcription results from the
accumulation of the viral protein Tat (14, 20). We therefore
investigated how COUP-TF affects LTR-driven transcription in
the presence of Tat. Because our transcription results obtained
in primary cells could be compared with those obtained with
the microglial cell line (38), we used the cell line to perform a
series of experiments that necessitated a large number of cells.
Microglial cells were transfected with various LTR-CAT re-
porter vectors, presented in Fig. 5, either alone or in the pres-
ence of vectors expressing COUP-TF, Tat, or a combination of
both vectors.
With LTR-CAT containing the full-length 2489/180 LTR
region, COUP-TF alone activated transcription 4-fold. Tat
alone or in combination with COUP-TF activated transcription
30-fold (results not shown). As shown previously, the truncated
268/180 region, containing two Sp1 sites and the TATA box,
was still able to mediate COUP-TF responsiveness (Fig. 5, lane
2), as a result of the direct interaction of COUP-TF with the
Sp1 protein (18). With this 268/180 LTR-CAT vector, Tat
alone or in combination with COUP-TF stimulated CAT activ-
ity 35-fold (Fig. 5, lanes 3 and 4).
Deletion of the TAR region, the binding site of Tat (43) in
268/129LTR-CAT, did not significantly affect COUP-TF-me-
diated stimulation (Fig. 5, lane 6), and as expected, it abolished
Tat-induced activation (lanes 7 and 8). Deletion or mutation of
the Sp1 sites in the truncated 240/180 LTR, in 2283/180
LTRSp1mut, or in 2283/180DkB/Sp1 led to the abolition of
COUP-TF-induced activation (Fig. 5, lanes 10, 14, and 18)
because Sp1 is required for COUP-TF transactivation in micro-
glial cells (18); similarly, Tat-induced activation was abolished
(lanes 11, 15, and 19), because Sp1 is required for efficient Tat
transactivation (26, 28). Surprisingly, overexpression of the
combination of Tat and COUP-TF resulted in a 8–14-fold tran-
scriptional stimulation (lanes 12, 16, and 20).
To determine whether this COUP-TF/Tat cooperation re-
quires the cognate HIV-1 TATAA region, we constructed a
vector containing the 240/180 LTR region in which the HIV-1
TATA sequence (TATAAGC) was replaced with the SV40 TATA
box (TATTTAT). Transfection experiments performed with the
240/180-SV40-TATA-CAT vector showed that COUP-TF or
Tat overexpression was unable to stimulate transcription, sim-
ilar to the results obtained with the nonmutated vector. How-
ever, overexpression of both COUP-TF and Tat in the presence
of the mutated vector did not lead to any increase in CAT
activity, indicating that COUP-TF is able to discriminate be-
tween different versions of TATAAs (result not shown).
These findings reveal a functional synergism between
COUP-TF and Tat, able to transactivate the LTR in the ab-
sence of NF-kB and Sp1 sites. These results further suggest
that Tat and COUP-TF are able to interact, directly or
indirectly.
Domains of COUP-TF and Tat Involved in the Synergistic
FIG. 4. COUP-TF stimulates HIV-1
replication in primary cultured hu-
man microglial cells. Immunostaining
by anti-p24 HIV-1 antigen of microglial
cells infected with HIV-1 (LAI) and either
left untransfected (A) or transfected with
COUP-TF (B). Photographs at a low mag-
nification (3 100) show the staining
(brown) of a cluster of transfected cells,
whereas control infected cells remained
unstained. At a higher magnification (3
400), aspect of infected and transfected
cells stained either with anti-p24 HIV-1
antigen (C) or with anti-Tat HIV-1 anti-
gen (D).
COUP-TF and Tat Interact and Stimulate HIV-1 Replication 2657
 by guest on M
arch 4, 2015
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Transcriptional Activation—To investigate which region of
COUP-TF was involved in the synergistic effect with Tat, we
used the pRSV-COUPdel148 vector expressing a C-terminal
truncated form of COUP-TF. Transfection experiments were
performed with 268/180 LTR-CAT and pRSV-COUPdel148 in
the presence or absence of CMV-Tat (Fig. 6A). The truncated
COUP-TF was unable to stimulate CAT activity (lane 2), be-
cause we have shown previously that the C-terminal domain of
COUP-TF is essential for its transcriptional activity (18). In-
terestingly, in the presence of Tat, overexpression of the trun-
cated COUP-TF led to a 50% inhibition of Tat-mediated acti-
vation (lane 4). This result reveals the dominant negative role
of the C-terminal truncated protein on Tat activity as well as
the importance of the C-terminal region for the synergistic
effect with Tat.
To examine the role of a transactivation negative form of Tat
on COUP-TF activity, we performed cotransfection experi-
ments using the 268/180 LTR-CAT and pCMV-Tat 72RP18IS,
expressing a transactivation negative Tat protein, in the pres-
ence or absence of RSV-COUP-TF (Fig. 6B). As expected, the
transactivation negative Tat mutant was unable to stimulate
CAT activity (lane 3). Interestingly, overexpression of this Tat
mutant led to a 50% inhibition of COUP-TF-mediated tran-
scriptional stimulation (lane 4). This result suggests that the
mutated form of Tat is able to inhibit the binding of COUP-TF
to Sp1 proteins either by masking the DBD domain of
COUP-TF or by competing for interactions with Sp1.
COUP-TF and Tat Interact in Vitro and in Cells—To deci-
pher the mechanism whereby COUP-TF and Tat mediate a
Sp1- and kB-independent transcriptional synergistic activa-
tion, we examined whether COUP-TF and Tat interact in vitro.
We performed GST pull-down experiments with GST-COUP
fusion proteins and 35S-labeled Tat. Results showed that 35S-
labeled Tat (Fig. 7B, lane 1) associates with the GST-COUP-1
fusion protein (lane 3). Under the experimental conditions,
about 1–2% of the total added Tat bound to GST-COUP. This
association was specific, because Tat bound to GST-COUP-1,
but not to the control GST protein alone (Fig. 7B, lane 2). To
localize the domain of COUP-TF that mediates interaction with
Tat, we used the GST-COUP-3 expression vector encoding res-
idues 49 to 148 of COUP-TF. The truncated GST-COUP-3 was
still able to mediate association with Tat (Fig. 7A, lane 4),
indicating that the N-terminal part of COUP-TF containing the
DNA-binding domain (Fig. 7A) is sufficient for interaction with
Tat in vitro.
The Tat protein is composed of distinct structural domains,
presented in Fig. 7A. We examined which domain of Tat asso-
ciates with COUP-TF, by using various GST-Tat mutants. Fig.
7C shows that the GST fusion proteins containing 86R Tat
(lane 3), the truncated 72R Tat (lane 4), and the mutant
72RP18IS Tat containing exon 1 and an insertion between
amino acids 18 and 19 (lane 5) were all able to interact with
COUP-TF; in contrast, GST fusion proteins Tat 48D and
48DP18IS, truncated after amino acid 48, were unable to bind
COUP-TF (lanes 6 and 7), similar to the GST control (lane 2).
About 1–2% of the total added COUP bound to GST-Tat. These
results indicate that in vitro association of Tat with COUP-TF
does not depend on exon 2 and requires the Tat region located
between amino acids 48 and 72. This region is formed by the
basic domain, at amino acids 48–58, which is known to mediate
specific binding to TAR RNA, and the C-terminal domain, at
amino acids 58–72.
We next investigated whether COUP-TF and Tat were able
to associate within cells. Microglial cells were transfected with
the CMV-Tat expression vector (Fig. 7D, lane 3) or left untrans-
fected (lane 2). Nuclear extracts were used for co-immunopre-
cipitation experiments. The ability of monoclonal anti-Tat an-
tibodies to coimmunoprecipitate the COUP-TF protein was
visualized by Western blotting with COUP-TF antibodies (Fig.
7D). These data confirm the existence of a direct association
between Tat and COUP-TF within cells.
DISCUSSION
In the present work, we have established the importance of
the nuclear receptor COUP-TF as an activator of HIV-1 gene
transcription and replication in primary microglia, the main
target of HIV-1 in brain. Overexpression of COUP-TF is able to
stimulate viral expression of not only the macrophage-tropic
FIG. 5. Tat and COUP-TF synergistically activate HIV-1 gene transcription directed from a NF-kB and Sp1-deleted or mutated
LTR region. Microglial cells were cotransfected with the indicated LTR-CAT expression vectors (1 pmol) in the presence or absence of vectors
expressing COUP-TF (2 mg) and Tat (10 ng), as indicated. Histograms represent CAT activities expressed relative to the value obtained with the
corresponding LTR-CAT reporter vector. Values correspond to an average of at least three independent experiments done in duplicate.
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95.33 strain but also of the lymphotropic LAI HIV-1 strain,
previously described to poorly replicate in microglia (44). Our
findings highlight the unexpected role of COUP-TF, which
appears to possess a transactive ability similar to that of the
transcription factors Sp1 and NF-IL6. These nuclear factors
are essential for inducing HIV-1 gene transcription in the im-
mediate-early phase of HIV infection, when viral transcription
proceeds at a low rate prior to the participation of viral acti-
vating proteins. Our run-on data show that COUP-TF stimu-
lates transcription by acting at the level of initiation.
The action of these cellular proteins leads to the early phase
of HIV infection and to the production of the viral protein Tat
(14, 20). By a series of in vitro and in vivo experiments, we have
demonstrated the existence of a novel physical and functional
interaction between the transcription factor COUP-TF and the
viral transactivator Tat. In vitro GST pull-down experiments
indicate that the N-terminal part of COUP-TF containing the
DNA-binding domain is sufficient for interaction with Tat. In
vitro association of Tat with COUP-TF does not depend on exon
2 and requires the Tat region located between amino acids 48
and 72 (formed by the basic domain, which mediates specific
binding to TAR RNA) and the C-terminal domain (amino acids
58–72). Interestingly, the regions involved in the protein-pro-
tein interaction are similar to those described for the thyroid
hormone receptor, another member of the nuclear receptor
superfamily. T3Ra also interacts with Tat through amino acids
present in the DNA-binding domain of the receptor; the basic
and C-terminal regions of Tat are involved in the binding to
T3Ra (32). In addition, our data obtained with microglial cells
transfected with a Tat expression vector confirm that Tat and
COUP-TF are able to interact directly within cells. Recent data
showed that Sp1 binds Tat amino acids 20–55 (45). When these
data are considered together, one could suspect that a ternary
complex of COUP-TF, Sp1, and Tat represents the functionally
important molecule. However, we show here that a synergistic
effect between COUP-TF and Tat is observed only in the ab-
sence of Sp1 sites, whereas the Sp1 and COUP-TF proteins
lead to a synergistic transcriptional increase in the presence of
Sp1 sites (18). This suggests that COUP-TF interacts prefer-
entially with either Sp1 bound to its DNA site or to Tat bound
to the TAR element. Moreover, Tat and Sp1 both interact with
the same N-terminal region of COUP-TF, which further
strengthens the idea that the binary complexes COUP-TF/Sp1
and COUP-TF/Tat are functionally important.
A number of reports have demonstrated that the Sp1 and kB
sequences are required for TAR-dependent transactivation by
Tat (26, 28–31, 33). Here, our studies with various LTR mu-
tants reveal that an interaction between COUP-TF and Tat can
lead to NF-kB- and Sp1-independent enhanced transactivation
of the HIV-1 LTR, in the presence of an intact TAR element.
Previous reports have shown that replication of HIV-1 of which
the Sp1 sites had been deleted was efficient in MT4 lympho-
cytes and in activated peripheral blood lymphocytes and ap-
peared to require NF-kB as a substitute for Sp1 (46). Here, our
data suggest an alternative regulatory pathway for Tat trans-
activation in microglia that is independent of both NF-kB and
Sp1, through direct interactions of Tat with the nuclear recep-
tor COUP-TF.
The following model may account for the interaction of the
FIG. 6. Domains of COUP-TF and Tat involved in the synergis-
tic transcriptional activation. A, microglial cells were transfected
with 1 pmol of 268/180 LTR-CAT vector and 0.5 pmol of pRSV-COUP-
del148 (lane 2) in the presence (lane 4) or absence (lane 3) of 10 ng of
CMV-Tat. B, cells were transfected with 0.5 pmol of pCMV-Tat
72RP18IS vector, expressing a transactivation-negative Tat protein, in
the presence (lane 4) or absence (lane 3) of 0.5 pmol of RSV-COUP-TF.
Histograms represent CAT activities expressed relative to the value
obtained with the corresponding 268/180 LTR-CAT reporter vector.
Values correspond to an average of at least three independent experi-
ments done in duplicate.
FIG. 7. The viral protein Tat and the nuclear receptor
COUP-TF interact in vitro and in vivo. A, schematic representation
of the domains present in the Tat protein and in the GST-COUP-TF
constructs. B, GST-COUP-1 and -3 fusion proteins interact with in vitro
translated 35S-Tat in GST pull-down assays. 35S-Tat (1 ml) (lane 1) was
translated in wheat germ lysate using the TNT kit (Promega) and
incubated with bacterially expressed GST (5 mg) (lane 2) or GST-
COUP-1 and -3 (3 mg) (lanes 3 and 4) immobilized on glutathione-
Sepharose beads. After extensive washing, the bound proteins were
eluted and analyzed by SDS-polyacrylamide gel electrophoresis fol-
lowed by autoradiography. Lane 1, input Tat (1 ml); lanes 2–4, GST and
GST-COUP incubated with 35S-Tat (15 ml). C, interactions of in vitro
translated 35S-COUP-TF with different GST-Tat mutants in GST pull-
down assays. 35S-COUP-TF (0.1 ml) (lane 1) was incubated with GST (5
mg) (lane 2) or GST-Tat proteins (3 mg) (lanes 3–7) immobilized on
glutathione-Sepharose beads. After washing, the bound proteins were
eluted and analyzed by SDS-polyacrylamide gel electrophoresis fol-
lowed by autoradiography. Lane 1, input COUP-TF (0.1 ml); lanes 2–7,
GST and GST-Tat mutants incubated with 35S-COUP-TF (15 ml). D,
co-immunoprecipitation of Tat and COUP-TF. Nuclear extracts from
microglial cells, previously transfected or not with CMV-Tat, were
immunoprecipitated with monoclonal anti-Tat antibodies. Nuclear pro-
tein extracts (10 mg) (lane 1) and immunoprecipitates from 50 mg of
nuclear proteins (lanes 2 and 3) were analyzed for the presence of
COUP-TF by Western blot analysis.
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nuclear receptor COUP-TF and viral Tat in regulating the
HIV-1 LTR. In the presence of Sp1 sites, the DNA-binding
domain of COUP-TF associates with the Sp1 protein bound to
its DNA binding site (18). In such a situation, COUP-TF is
unable to interact with Tat and thus is unable to synergize with
Tat. In contrast, in the absence of Sp1 sites, COUP-TF appears
to be able to recruit Tat and to substitute for the Sp1 protein.
However, this effect is TAR-dependent and requires binding of
Tat to TAR. As shown here, the DNA-binding domain of
COUP-TF binds to Tat, whereas the C terminus of COUP-TF
interacts with the general transcription factor TFIIB, as de-
scribed previously (47). These interactions may thus anchor
Tat to the transcriptional apparatus. However, this recruit-
ment is insufficient for Tat activity as it does not permit a TAR
independent transactivation. It is clear that the precise molec-
ular mechanisms need to be further investigated.
The nuclear receptor COUP-TF is known to be ubiquitously
expressed, including in T lymphocytes, the main target of
HIV-1 in the immune system. Similar to its action in microglia,
COUP-TF functions as a transcriptional activator in lympho-
cytes, by acting through the Sp1 element of the HIV-1 LTR (48).
Because our data in CNS cells revealed the unexpected role of
COUP-TF in the presence of Tat, it will be interesting in
further studies to examine the role of COUP-TF in the regula-
tion of various HIV-1 strains in cells of the immune system.
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